Electrical storm is a potent risk factor for mortality and morbidity

August 27, 2012

Electrical storm (ES) is a potent risk factor for mortality and morbidity, according to research presented today, August 26, at the ESC Congress 2012 by Dr Federico Guerra from Italy. Data was also presented on which patients are prone to developing ES and how effective current treatments are.

Sustained ventricular arrhythmias, such as ventricular (VT) or (VF), are often seen as serious and devastating events, given their ability to lead to and death if not treated promptly. Dr Guerra said: "The cluster of three or more of those arrhythmias within a 24 hour timeframe is usually called electrical storm (ES), the most devastating of all arrhythmic complications."

ES is more frequently seen as an acute complication of but is not uncommonly related to other , such as cardiomyopathies, congenital and Brugada syndrome. The highest incidence of ES is however reported in patients with an implantable cardioverter defibrillator (ICD). "This incidence, which ranges from 4% to 60%, is mainly due to two factors," said Dr Guerra. "First, ICD can detect the VT or VF underlying a clinical episode of , syncope or even aborted sudden cardiac death, thus making the diagnosis far easier. Second, and most important, it can effectively treat the first and second VT or VF, thus saving the patient from and making him able to withstand more arrhythmic episodes."

The aim of the study was to collect all the data available regarding ES to see its real impact as a risk factor for death and impaired . The researchers conducted the largest meta-analysis of ES to date and pooled together 6,979 patients with ICD implantation from 32 different studies. Dr Guerra said: "We sought to investigate whether there are any clues that enable us to predict ES, or at least tell us if some specific types of patients will be more prone to develop ES. Finally, we wanted to check what types of treatments are currently available for ES, and compare them in terms of efficacy and safety."

The researchers found that ES was a strong risk factor for death. Compared to patients with multiple VTs or VFs but no ES, patients with ES were nearly 4 times more likely to die from cardiac causes, and 5 times more likely to experience either cardiovascular death, heart transplantation, or cardiogenic shock. Patients with ES were also 9 times more likely to die from any cause than patients without any previous ventricular arrhythmias.

The researchers also found some specific subgroups of patients in which ES was more frequent. "Patients who had an ICD implanted because they have already experienced a VT or VF have the highest probability of developing ES," said Dr Guerra. "Patients with severe impairment of heart function and disabling symptoms of heart failure are also more prone to ES. And a specific subtype of VT, called monomorphic VT, is frequently followed by other arrhythmic episodes, which often culminates in ES."

When the researchers analyzed available treatments for ES they found that pharmacological treatment was often ineffective for terminating acute episodes or preventing recurrences. But Dr Guerra said: "The ablation of specific zones inside the heart by means of little catheters inserted from a peripheral blood vessel can provide effective termination of ES in nearly 83% of the cases, preventing relapses over the following years."

"Our work confirmed ES as a potent risk factor for mortality and morbidity," he added. "Even if it is still not possible to predict ES with certainty, our work helped to recognize specific subtypes of patients who are more prone to develop ES. Doctors can use this information to identify which of their patients are at risk of ES and take appropriate preventative measures. We also found that pharmacological therapy performs poorly in ES patients and should be accompanied by catheter ablation whenever possible, especially in a high-risk setting."

Related Stories

Recommended for you

How genes and environment interact to raise risk of congenital heart defects

October 19, 2017
Infants of mothers with diabetes have a three- to five-fold increased risk of congenital heart defects. Such developmental defects are likely caused by a combination of genetic and environmental factors. However, the molecular ...

Mouse studies shed light on how protein controls heart failure

October 18, 2017
A new study on two specially bred strains of mice has illuminated how abnormal addition of the chemical phosphate to a specific heart muscle protein may sabotage the way the protein behaves in a cell, and may damage the way ...

Newborns with trisomy 13 or 18 benefit from heart surgery, study finds

October 18, 2017
Heart surgery significantly decreases in-hospital mortality among infants with either of two genetic disorders that cause severe physical and intellectual disabilities, according to a new study by a researcher at the Stanford ...

Saving hearts after heart attacks: Overexpression of a gene enhances repair of dead muscle

October 17, 2017
University of Alabama at Birmingham biomedical engineers report a significant advance in efforts to repair a damaged heart after a heart attack, using grafted heart-muscle cells to create a repair patch. The key was overexpressing ...

Physically active white men at high risk for plaque buildup in arteries

October 17, 2017
White men who exercise at high levels are 86 percent more likely than people who exercise at low levels to experience a buildup of plaque in the heart arteries by middle age, a new study suggests.

High blood pressure linked to common heart valve disorder

October 17, 2017
For the first time, a strong link has been established between high blood pressure and the most common heart valve disorder in high-income countries, by new research from The George Institute for Global Health at the University ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.